Clinical Trial Update: Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) [Phase 2]

View source ↗

Summary

Phase 2 REVIVE trial evaluating a hepcidin mimetic in polycythemia vera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Hepcidin mimetic

Snippet

Sponsor: Protagonist Therapeutics, Inc. | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED